Original Contribution
Role of labile iron in the toxicity of pharmacological ascorbate
Graphical abstract
Introduction
Pharmacological ascorbate has been shown to induce toxicity in cancer cells both in vitro and in vivo [1], [2], [3]. Pharmacological concentrations of ascorbate produce hydrogen peroxide via the formation of ascorbate radical (Asc•-) [4]. In in vitro environments, the rate of ascorbate oxidation is principally a function of the level of catalytically active iron and copper [5], [6]. For example, catalytic iron in cell culture media containing ascorbate contributes significantly to the rate of H2O2 generation; Dulbecco’s modification of Eagle’s MEM (DMEM) generates more H2O2 than RPMI 1640 during a 6-h incubation with increasing concentration of ascorbate [7] due to the fact that DMEM has an additional 0.25 μM Fe(NO3)3 in its formulation in addition to any adventitious iron.
Extracellular H2O2 readily diffuses into cells [8]; if not removed, it can lead to oxidative damage to proteins, lipids, and DNA [9]. These detrimental oxidations require that H2O2 be “activated” by appropriate redox-active transition metals, such as iron [10], [11]; labile iron, i.e., redox-active iron associated with macromolecules, will lead to production of hydroxyl radical (HO•) causing site-specific damage [12], [13]. Intracellular labile iron can be coordinated by chelators such as deferoxamine (DFO), blunting their catalytically activity [14], and thereby protecting cells from H2O2-induced DNA damage [15]. Conversely, increasing intracellular iron can enhance H2O2-induced injury as seen with cardiomyocytes [16]. Preincubation of the epithelial cell line CNCMI221 with Fe3+/8-hydroxyquinoline enhanced the observed cytotoxic effects of H2O2 [17]. It is well known that the primary oxidant generated by the Fenton reaction (H2O2 + Fe2+) is the hydroxyl radical, HO• [18]. HO• is very reactive and as such has an extremely limited diffusion distance, only about 6 nm in cells [19]. In cell culture experiments, introduction of Fe2+ to media containing H2O2 can actually protect cells [20], [21] because the H2O2 in the media is removed; HO• generated by the Fenton reaction in the media will have little consequence, as the majority will react with media components and not cells. Removal of extracellular H2O2 will minimize any possible site-specific oxidative damage to intracellular macromolecules, such as DNA.
We hypothesized that altering the concentration of iron would affect ascorbate-induced cytotoxicity: (1) by altering the rate of oxidation of ascorbate and thus the rate of production of H2O2; and (2) altering the rate of activation of H2O2 by intracellular labile iron, thereby altering the oxidative damage to cellular macromolecules, e.g., DNA, induced by site-specific production of HO•. We found that treatment of cells with iron-chelators decreased H2O2 generation and reversed ascorbate-induced toxicity while increasing intracellular iron enhanced ascorbate-induced cytotoxicity. Our study indicates that redox-active metals, both inside and outside the cell, play an important role in ascorbate-induced cytotoxicity.
Section snippets
Chemicals
Iron (III) chloride (FeCl3), deferoxamine mesylate, 2,2′-dipyridyl (DPD), 8-hydroxyquinoline (8-HQ), and ascorbic acid 2-phosphate sesquimagnesium salt hydrate (Asc-2 P) were from Sigma (St. Louis, MO). L-Ascorbic acid was purchased from Macron Chemicals (Center Valley, PA). Stock solutions of ascorbate (1.0 M) were made as previously described [3]. Phen Green SK diacetate (PG SK) was from Life Technologies (Grand Island, NY). Prior to use, DPD and PG SK were initially dissolved in a small amount
Iron chelators can protect cells from ascorbate-induced cytotoxicity
The oxidation of ascorbate in aqueous solution, in cell culture media, or in extracellular fluid is primarily dependent on the presence of catalytic metal ions [5], [6], [25]. To investigate the role of iron in ascorbate-induced cytotoxicity, cells were exposed to metal chelators DFO (75 µM) or DPD (50 µM) in HBSS for 1 h followed by addition of 2 mM ascorbate in DMEM–10% FBS for 1 h (Fig. 1A). There was no difference in clonogenic survival for cells treated with either DFO (41 ± 3%) or DPD (40 ±
Discussion
The effects of iron on ascorbate oxidation-induced cytotoxicity are not straightforward. Chelating the adventitious catalytic metals with DTPA or DFO slows ascorbate oxidation in phosphate buffer at neutral pH [5]. However, preincubation of ascorbate (500 μM) with apo-Tf (50 μg/mL) or 500 μM DFO, ferrozine, or DTPA and then incubating human dermal fibroblasts (HDFs) with these solutions did not prevent DNA damage induced by ascorbate oxidation [33]. In our experimental settings, we found that
Acknowledgments
This work was supported by NIH Grants U01 CA166800, R01 CA169046, R01 GM073929, and the Medical Research Service, Department of Veterans Affairs 1I01BX001318-01A2. Core facilities were supported in part by NIH P30 CA086862. The University of Iowa ESR Facility provided invaluable support. Data presented herein were obtained at the Flow Cytometry Facility, which is a Carver College of Medicine/Holden Comprehensive Cancer Center core research facility at the University of Iowa. The Facility is
References (48)
In the absence of catalytic metals, ascorbate does not autoxidize at pH 7: ascorbate as a test for catalytic metals
J. Biochem. Biophys. Methods
(1988)- et al.
An assay for the rate of removal of extracellular hydrogen peroxide by cells
Redox Biol
(2013) - et al.
Fluorescein diacetate is superior for detecting intracellular oxidants: comparison to 2׳7׳ dichlorodihydrofluorescein diacetate, 5(and 6)-carboxy-2׳7׳-dichlorodihydrofluorescein diacetate and dihydrorhodamine 123
Free Radic. Biol. Med.
(1999) - et al.
Formation, prevention, and repair of DNA damage by iron/hydrogen peroxide
J. Biol. Chem.
(1997) In the absence of catalytic metals, ascorbate does not autoxidize at pH 7: ascorbate as a test for catalytic metals
J. Biochem. Biophys. Methods
(1988)- et al.
Intracellular iron, but not copper, plays a critical role in hydrogen peroxide-induced DNA damage
Free Radic. Biol. Med.
(2001) - et al.
Extracellular iron(II) can protect cells from hydrogen peroxide
Arch. Biochem. Biophys.
(1996) - et al.
Iron and dioxygen chemistry is an important route to initiation of biological free radical oxidations: An electron paramagnetic resonance spin trapping study
Free Radic. Biol. Med.
(1999) - et al.
A simple and sensitive assay for ascorbate using a plate reader
Anal. Biochem.
(2007) - et al.
Thermodynamic and kinetic considerations for the reaction of semiquinone radicals to form superoxide and hydrogen peroxide
Free Radic. Biol. Med.
(2010)
Hydrogen peroxide-mediated cytotoxicity to cultured colonic epithelial cells
Life Sci.
Studies of Fe3+ transport across isolated intestinal brush-border membrane of the mouse
Biochim. Biophys. Acta
Regulation of the transferrin-independent iron transport system in cultural cells
J. Biol. Chem.
The rate of oxygen utilization by cells
Free Radic. Biol. Med.
Investigation of the role of extracellular H2O2 and transition metal ions in the genotoxic action of ascorbate in cell culture models
Toxicol. Lett.
Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells
Blood
The active role of vitamin C in mammalian iron metabolism: much more than just enhanced iron absorption!
Free Radic. Biol. Med.
Non-transferrin bound iron: a key role in iron overload and iron toxicity
Biochim. Biophys. Acta
The labile iron pool: characterization, measurement and participation in cellular process
Free Radic. Biol. Med.
Calcein as a fluorescent probe for ferric iron. Application to iron nutrition in plant cells
J. Biol. Chem.
The importance of sodium pyruvate in assessing damage produced by hydrogen peroxide
Free Radic. Biol. Med
Synthetic lethal screening identifies compounds activating iron-dependent, non-apoptotic cell death in oncogenic-RAS-harboring cancer cells
Chem. Biol.
Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects
Free Radic. Biol. Med.
Role of intracellular labile iron, ferritin, and antioxidant defence in resistance of chronically adapted Jurkat T cells to hydrogen peroxide
Free Radic. Biol. Med.
Cited by (55)
-
Stability of aqueous solutions of ascorbate for basic research and for intravenous administration
2023, Advances in Redox Research -
New promising developments for potential therapeutic applications of high-dose ascorbate as an anticancer drug
2021, Hematology/ Oncology and Stem Cell TherapyCitation Excerpt :Interestingly, using 18F-TRX, a positron emission tomography (PET) probe of labile ferrous iron, it was possible to measure dynamic changes at the level of LIP in vivo [50]. There is a double relationship between LIP and ascorbate in that pharmacological doses of ascorbate increase LIP of tumor cells, as shown in a pancreatic cancer model [51], and an increase of LIP in tumor cells increases the toxicity of pharmacological doses of ascorbate [52]. Thus, it was shown that tumor cells incubated with soluble iron donors, such as Fe hydroxyquinoline, exhibited an increased ascorbate-mediated toxicity, whereas iron-deprived cells using iron chelators displayed a reduced sensitivity to ascorbate toxicity [52].
-
Pharmacological ascorbate and use in pancreatic cancer
2021, Cancer: Oxidative Stress and Dietary Antioxidants